跳至主要内容
临床试验/NCT02043886
NCT02043886已完成2 期

The Use of Acarbose to Treat Postprandial Hypotension in Older Adults With Type 2 Diabetes

University of British Columbia1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
15
试验地点
1
主要终点
Heart rate

研究概览

简要总结

Postprandial hypotension carries a risk of significant morbidity and morbidity including syncope, falls, dizziness, fatigue, stroke and myocardial infarction. Current therapy consists of dietary manipulation (smaller meals) caffeine and octreotide injections all of which are suboptimal and poorly studied.

The study hypothesis is that administration of Acarbose will decrease the drop in blood pressure and increase in heart rate in response to food in people with Type 2 diabetes.

Acarbose suppresses postprandial glycemia be slowing digestion in the small intestine and delaying gastric emptying.

This is a placebo-controlled cross over study involving 2 - 4 hour Meal Tests. During the meal tests heart rate, blood pressure, cerebral artery velocity will be measured. During one meal test subjects will receive Acarbose 50 mg po and during the other will receive placebo. Order of treatment assignment will be done in randomized fashion. A total of approximately 200 cc of blood will be drawn during each meal test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 65 year and older
  • Type 2 diabetes

排除标准

  • less than 65 years of age

研究组 & 干预措施

Acarbose

Active Comparator

Acarbose 50mg by mouth at minute 0 of the Meal Test.

干预措施: Acarbose (Drug)

Placebo

Placebo Comparator

Placebo 1 tablet at 0 minutes of Meal Test.

干预措施: Placebo (Drug)

结局指标

主要结局

Heart rate

时间窗: continuously during Meal Test; about 4 hours

Heart rate will be measured continuously by Finometer during the Meal Tests. Each Meal Test will take approximately 4 hours

Blood pressure

时间窗: Continuously during Meal Tests (approximately 4 hours)

Blood pressure will be measured continuously by Finometer during each of the Meal Tests (approximately 4 hours)

Middle cerebral artery velocity

时间窗: continuously during Meal Tests (approximately 4 hours)

Middle cerebral artery velocity will be measure continuously by transcranial doppler during the Meal Tests (approximately 4 hours)

Serum glucose

时间窗: Every 15 minutes during Meal Tests

Serum glucose will be measured using a YSI (Yellow Spring Instruments) Stat 2300 Blood Glucose Analyzer

Serum insulin

时间窗: Every 15 minutes during Meal Tests (approximately 4 hours)

Serum insulin levels will be collected every 15 minutes during the Meal Tests (approximately 4 hours) and analyzed by Elisa (enzyme linked immunoabsorbant) assays.

Serum peptides: GIP (gastric inhibitory polypeptide) and GLP-1 (glucagon like peptide)

时间窗: Every 15 minutes during Meal Tests (approximately 4 hours)

Serum peptides will be collected every 15 minutes for the duration of the Meal Tests (approximately 4 hours) and analyzed by Elisa (enzyme linked immunoabsorbant) assays.

Catecholamines

时间窗: Continuously during Meal Test (approximately 4 hours)

Serum insulin levels will be collected every 15 minutes during the Meal Tests (approximately 4 hours) and analyzed by Elisa (enzyme linked immunoabsorbant) assays.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenneth Madden

Principal Investigator

University of British Columbia

研究点 (1)

Loading locations...

相似试验